Pharmacological activity of DTPA linked to protein-based drug carrier systems
- 29 October 2004
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 323 (4) , 1236-1240
- https://doi.org/10.1016/j.bbrc.2004.08.223
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of ChelatorsCurrent Medicinal Chemistry, 2003
- Antiviral and immunomodulatory activity of the metal chelator ethylenediaminedisuccinic acid against cytomegalovirus in vitro and in vivoAntiviral Research, 2002
- Therapeutic Potential of Iron Chelators in Cancer TherapyPublished by Springer Nature ,2002
- Intracellular Chelation of Iron by Bipyridyl Inhibits DNA Virus ReplicationPublished by Elsevier ,2001
- Cellular zinc status regulates cytomegalovirus major immediate-early promoter.Antiviral Research, 2000
- ANTIVIRAL AND IMMUNOMODULATORY EFFECTS OF DESFERRIOXAMINE IN CYTOMEGALOVIRUS-INFECTED RAT LIVER ALLOGRAFTS WITH REJECTION1Transplantation, 1999
- Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivoAntiviral Research, 1999
- In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acidAntiviral Research, 1996
- Role of Deferoxamine in Tumor TherapyActa Haematologica, 1996
- In vitro inhibition of human cytomegalovirus replication by desferrioxamineAntiviral Research, 1994